Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Bitsios, E. Szabadi, C. Bradshaw (1999)
Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in manPsychopharmacology, 143
C. Hysek, L. Simmler, V. Nicola, N. Vischer, M. Donzelli, S. Krähenbühl, E. Grouzmann, J. Huwyler, M. Hoener, M. Liechti (2012)
Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory StudyPLoS ONE, 7
S. Nieuwenhuis, I. Nieuwpoort, D. Veltman, M. Drent (2007)
Effects of the noradrenergic agonist clonidine on temporal and spatial attentionPsychopharmacology, 193
T. Tham, S. Guy, B. McDermott, R. Shanks, J. Riddell (1995)
The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.British journal of clinical pharmacology, 40 1
M. Tancer, C. Johanson (2006)
The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humansPsychopharmacology, 189
Mehmet Sofuoglu, Scott Brown, D. Babb, Paul Pentel, Dorothy Hatsukami (2000)
Carvedilol affects the physiological and behavioral response to smoked cocaine in humans.Drug and alcohol dependence, 60 1
R. Rothman, M. Baumann, C. Dersch, Dana Romero, K. Rice, F. Carroll, J. Partilla (2001)
Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninSynapse, 39
I. Loewenfeld, O. Lowenstein (1999)
The Pupil: Anatomy, Physiology, and Clinical Applications
L. Simmler, C. Hysek, M. Liechti (2011)
Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.The Journal of clinical endocrinology and metabolism, 96 9
L. Noehr-Jensen, S. Zwisler, F. Larsen, S. Sindrup, P. Damkier, F. Nielsen, K. Brøsen (2009)
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarkerEuropean Journal of Clinical Pharmacology, 65
C. Hysek, R. Brugger, L. Simmler, M. Bruggisser, M. Donzelli, E. Grouzmann, M. Hoener, M. Liechti (2012)
Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy VolunteersJournal of Pharmacology and Experimental Therapeutics, 340
M. Liechti, F. Vollenweider (2001)
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studiesHuman Psychopharmacology: Clinical and Experimental, 16
W. Taylor, Jeff Chen, H. Meltzer, T. Gennarelli, Cynthia Kelbch, S. Knowlton, Jenny Richardson, M. Lutch, A. Farin, K. Hults, L. Marshall (2003)
Quantitative pupillometry, a new technology: normative data and preliminary observations in patients with acute head injury. Technical note.Journal of neurosurgery, 98 1
C. Verrico, G. Miller, B. Madras (2006)
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatmentPsychopharmacology, 189
M. Koss, L. Logan, T. Gherezghiher (1988)
α-Adrenoceptor activation of nictitating membrane and iris in catsNaunyn-Schmiedeberg's Archives of Pharmacology, 337
H. Wittchen, U. Wunderlich, S. Gruschwitz, M. Zaudig (1997)
SKID I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearb. d. amerikanischen Originalversion des SKID I
M. Mithoefer, M. Wagner, A. Mithoefer, L. Jerome, R. Doblin (2011)
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyJournal of Psychopharmacology (Oxford, England), 25
M. Chung, V. Vashi, J. Puente, M. Sweeney, P. Meredith (1999)
Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.British journal of clinical pharmacology, 48 5
J. Hey, T. Gherezghiher, M. Koss (1988)
Atypical α-adrenoceptor Mediates Phenylephrine-Induced Mydriasis in Anesthetized CatsJournal of Ocular Pharmacology and Therapeutics, 4
M. Mas, M. Farré, R. Torre, P. Roset, J. Ortuño, J. Segura, J. Camí (1999)
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.The Journal of pharmacology and experimental therapeutics, 290 1
M. Phillips, E. Szabadi, C. Bradshaw (2000)
Comparison of the effects of clonidine and yohimbine on spontaneous pupillary fluctuations in healthy human volunteersPsychopharmacology, 150
C. Hysek, G. Domes, M. Liechti (2012)
MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotionsPsychopharmacology, 222
J. Schmitt, W. Riedel, E. Vuurman, M. Kruizinga, J. Ramaekers (2002)
Modulation of the Critical Flicker Fusion effects of serotonin reuptake inhibitors by concomitant pupillary changesPsychopharmacology, 160
B. Roelands, Maaike Goekint, E. Heyman, M. Piacentini, P. Watson, H. Hasegawa, L. Buyse, Frank Pauwels, G. Schutter, R. Meeusen (2008)
Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature.Journal of applied physiology, 105 1
C. Hysek, L. Simmler, M. Ineichen, Eric Grouzmann, M. Hoener, Rudolf Brenneisen, Jörg Huwyler, M. Liechti (2011)
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in HumansClinical Pharmacology & Therapeutics, 90
M. Hirohashi, K. Takasuna, K. Tamura, K. Yamaguchi, K. Maekawa, S. Yamada, S. Iwasaki, M. Yoshida, M. Nomura, K. Taguchi (1990)
General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.Arzneimittel-Forschung, 40 7
Mj Morley, C. Bradshaw, E. Szabadi (1991)
Effects of clonidine and yohimbine on the pupillary light reflex and carbachol-evoked sweating in healthy volunteers.British journal of clinical pharmacology, 31 1
K. Shirai, Mingling Song, J. Suzuki, T. Kurosu, T. Oyama, D. Nagayama, Y. Miyashita, Shigeo Yamamura, Mao Takahashi (2011)
Contradictory effects of β1- and α1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure.Journal of atherosclerosis and thrombosis, 18 1
S. Anavekar, B. Jarrott, M. Toscano, W. Louis (2004)
Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjectsEuropean Journal of Clinical Pharmacology, 23
R. Kramer, Marie Rubicek, P. Turner (1973)
The role of norfenfluramine in fenfluramine‐induced mydriasisJournal of Pharmacy and Pharmacology, 25
M. Farré, R. Torre, Brian Mathúna, P. Roset, Ana Peiró, M. Torrens, J. Ortuño, M. Pujadas, J. Camí (2004)
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokineticsPsychopharmacology, 173
J. Benjamin, H. Nemetz, M. Fux, I. Bleichman, G. Agam (1997)
Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder.Journal of psychiatric research, 31 4
HU Wittchen, U Wunderlich, S Gruschwitz, M Zaudig (1997)
SKID-I: Strukturiertes Klinisches Interview für DSM-IV
P. Heller, F. Perry, D. Jewett, J. Levine (1990)
Autonomic components of the human pupillary light reflex.Investigative ophthalmology & visual science, 31 1
Trefor Morgan (1994)
Clinical Pharmacokinetics and Pharmacodynamics of CarvedilolClinical Pharmacokinetics, 26
C. Hysek, Y. Schmid, A. Rickli, LD Simmler, M. Donzelli, E. Grouzmann, Melanie Liechti (2012)
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humansBritish Journal of Pharmacology, 166
M. Liechti, C. Baumann, A. Gamma, F. Vollenweider (1999)
Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor CitalopramNeuropsychopharmacology, 22
M. Liechti, A. Gamma, F. Vollenweider (2001)
Gender differences in the subjective effects of MDMAPsychopharmacology, 154
A. Keränen, S. Nykänen, J. Taskinen (1978)
Pharmacokinetics and side-effects of clonidineEuropean Journal of Clinical Pharmacology, 13
M. Phillips, P. Bitsios, E. Szabadi, C. Bradshaw (2000)
Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteersPsychopharmacology, 149
Panos Bitsios, R. Langley, E. Szabadi, C. Bradshaw (2003)
Comparison of the effects of clonidine on tyramine- and methoxamine-evoked mydriasis in man.British journal of clinical pharmacology, 41 4
L. Derogatis, K. Rickels, Anthony Rock (1976)
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report ScaleBritish Journal of Psychiatry, 128
B. Tomlinson, B. Prichard, B. Graham, R. Walden (2004)
Clinical pharmacology of carvedilolThe clinical investigator, 70
B. Tomlinson, F. Bompart, B. Graham, Jun-Bao Liu, B. Prichard (2012)
Vasodilating Mechanism and Response to Physiological Pressor Stimuli of Acute Doses of Carvedilol Compared with Labetalol, Propranolol and HydralazineDrugs, 36
Anette Nielsen, R. Pedersen, L. Noehr-Jensen, P. Damkier, K. Brøsen (2010)
Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol’s O-demethylation via CYP2D6European Journal of Clinical Pharmacology, 66
Tara White, A. Justice, H. Wit (2002)
Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phasePharmacology Biochemistry and Behavior, 73
Vassilis Koudas, A. Nikolaou, E. Hourdaki, S. Giakoumaki, P. Roussos, P. Bitsios (2009)
Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteersPsychopharmacology, 205
Erin Kolbrich, R. Goodwin, D. Gorelick, R. Hayes, E. Stein, M. Huestis (2008)
Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine AdministrationJournal of Clinical Psychopharmacology, 28
M. Prow, K. Martin, D. Heal (1996)
8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation.European journal of pharmacology, 317 1
T. Siepmann, T. Ziemssen, M. Mueck‐Weymann, W. Kirch, M. Siepmann (2007)
The Effects of Venlafaxine on Autonomic Functions in Healthy VolunteersJournal of Clinical Psychopharmacology, 27
M. Farré, S. Abanades, P. Roset, A. Peiró, M. Torrens, Brian O'Mathúna, M. Segura, R. Torre (2007)
Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and PharmacokineticsJournal of Pharmacology and Experimental Therapeutics, 323
M. Phillips, E. Szabadi, C. Bradshaw (2000)
Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels.British journal of clinical pharmacology, 50 1
L. Henderson, D. Tenero, Charlotte Baidoo, A. Campanile, Angela Harter, D. Boyle, T. Danoff (2006)
Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.The American journal of cardiology, 98 7A
N. Schmitz, N. Hartkamp, J. Ki-use, Gabriele Franke, G. Reister, Wolfgang Tress (2000)
The Symptom Check-List-90-R (SCL-90-R): A German validation studyQuality of Life Research, 9
E Szabadi, CM Bradshaw (1996)
Autonomic pharmacology of α2-adrenoceptorsJ Psychopharmacol, 10
J. Clifford, M. Day, J. Orwin (1982)
Reversal of clonidine induced miosis by the alpha 2-adrenoreceptor antagonist RX 781094.British journal of clinical pharmacology, 14 1
M. Liechti, F. Vollenweider (2000)
The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteersJournal of Psychopharmacology, 14
N. Theofilopoulos, G. Mcdade, E. Szabadi, C. Bradshaw (1995)
Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex.British journal of clinical pharmacology, 39 3
The MDMA-induced prolongation of the latency to and reduction of light-induced miosis indicate indirect central parasympathetic inhibition, and the faster recovery time reflects an increased sympathomimetic action. Both norepinephrine and serotonin mediate the effects of MDMA on pupillary function. Although mydriasis is lasting and mirrors the plasma concentration–time curve of MDMA, the impairment in the reaction to light is associated with the subjective and other autonomic effects of MDMA and exhibits acute tolerance.
Psychopharmacology – Springer Journals
Published: Dec 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.